Most patients with hepatocellular carcinoma have underlying liver disease and the optimal treatment is, therefore, liver transplantation. When liver transplantation is not possible clinicians must decide whether to resect or ablate the cancer. The author of this Viewpoint article discusses the advantages and disadvantages of these two approaches and their use in clinical practice.